Moneycontrol
    Moneycontrol PRO
    Loans
    Loans

    Uti Amc

    Jump to

    • Buy UTI AMC; target of Rs 1400: Motilal Oswal

      Motilal Oswal is bullish on UTI AMC has recommended buy rating on the stock with a target price of Rs 1400 in its research report dated January 21, 2026.

    • We believe markets still need a proper 10-15% correction: UTI AMC’s Ajay Tyagi

      In conversation with Moneycontrol, Tyagi spoke about why he believes the budget continues to be a “non-event” for the market and why he believes that consumption could finally see the much awaited turnaround.

    • UTI AMC Consolidated December 2025 Net Sales at Rs 517.13 crore, up 23.84% Y-o-Y

    • UTI AMC Standalone December 2025 Net Sales at Rs 423.12 crore, up 28.56% Y-o-Y

    • UTI AMC Consolidated September 2025 Net Sales at Rs 418.55 crore, down 22.26% Y-o-Y

    • UTI AMC Standalone September 2025 Net Sales at Rs 390.22 crore, down 6.34% Y-o-Y

    • UTI AMC announces leadership transition, stock trades in green

      UTI AMC announced that Imtaiyazur Rahman will be handing over charge as Managing Director & Chief Executive Officer effective from close of business hours on January 31, 2026

    • Buy UTI AMC; target of Rs 1650: Motilal Oswal

      Motilal Oswal is bullish on UTI AMC has recommended buy rating on the stock with a target price of Rs 1650 in its research report dated July 24, 2025.

    • UTI AMC Consolidated June 2025 Net Sales at Rs 546.89 crore, up 3.34% Y-o-Y

    • UTI AMC Standalone June 2025 Net Sales at Rs 436.88 crore, up 13.02% Y-o-Y

    • Buy UTI AMC; target of Rs 1550: Motilal Oswal

      Motilal Oswal is bullish on UTI AMC recommended buy rating on the stock with a target price of Rs 1550 in its research report dated June 13, 2025.

    • HDFC AMC, other AMC stocks see profit booking post-May AMFI data

      AMC stocks: While inflows into equity mutual funds declined, the monthly inflows into mutual funds through SIP route rose to a fresh high of Rs 26,688 crore in May.

    • UTI AMC Consolidated March 2025 Net Sales at Rs 375.91 crore, down 9.65% Y-o-Y

    • UTI AMC Standalone March 2025 Net Sales at Rs 316.88 crore, down 3.24% Y-o-Y

    • Buy UTI AMC; target of Rs 1250: Motilal Oswal

      Motilal Oswal is bullish on UTI AMC recommended buy rating on the stock with a target price of Rs 1250 in its research report dated April 30, 2025.

    • Should investors bet on a potential stake sale in this mutual fund?

      UTI AMC is one of the top 10 mutual fund houses in the country

    • AMCs likely to see decline in equity AUMs on QoQ basis amid market correction

      AMCs are expected to see a sharp sequential decline in equity AUMs for Q4 due to market corrections, with mid- and small-cap-focused schemes hit the hardest.

    • Buy UTI AMC; target of Rs 1300: Motilal Oswal

      Motilal Oswal is bullish on UTI AMC has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated January 28, 2025.

    • UTI AMC Consolidated December 2024 Net Sales at Rs 417.58 crore, down 7.01% Y-o-Y

    • UTI AMC Standalone December 2024 Net Sales at Rs 329.13 crore, down 4.91% Y-o-Y

    • UTI AMC Consolidated September 2024 Net Sales at Rs 538.40 crore, up 33.25% Y-o-Y

    • Nomura initiates ‘buy’ call on HDFC AMC, NAM, bullish on rising retail participation

      Currently, mutual fund assets under management in India account for only 18 percent of GDP, while the global average is 65 percent.

    • UTI AMC Standalone June 2024 Net Sales at Rs 386.56 crore, up 9.68% Y-o-Y

    • UTI AMC Consolidated June 2024 Net Sales at Rs 529.22 crore, up 13.14% Y-o-Y

    • UTI AMC Standalone March 2024 Net Sales at Rs 327.48 crore, up 24.44% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347